AR023566A1 - Un procedimiento para el dihidrato del hidrocloruro derivado de la tiazolidina-2,4-diona - Google Patents

Un procedimiento para el dihidrato del hidrocloruro derivado de la tiazolidina-2,4-diona

Info

Publication number
AR023566A1
AR023566A1 ARP000101868A ARP000101868A AR023566A1 AR 023566 A1 AR023566 A1 AR 023566A1 AR P000101868 A ARP000101868 A AR P000101868A AR P000101868 A ARP000101868 A AR P000101868A AR 023566 A1 AR023566 A1 AR 023566A1
Authority
AR
Argentina
Prior art keywords
thiazolidine
hydrochloride
diona
procedure
hydrochloride dihydrate
Prior art date
Application number
ARP000101868A
Other languages
English (en)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of AR023566A1 publication Critical patent/AR023566A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

Un procedimiento para prepara el dihidrdato de hidrocloruro de 5-[4-[2-(N-metil-N-2 piridil)etoxi]bencil]tiazolidina-2,4-diona, que: (i) proporciona unespectro infrarrojo que contiene picos a 3.392, 2.739, 1.751, 1.325 y 713 cm-1 y/o (ii) proporcionaun modelo de difraccion de rayos X a través de polvo (XRPD)que contiene picos a 9,1, 12,0, 15,7, 16,3 y 19,8s2theta, que 5-[4-[2-N-metil-N-(2-piridil)amino)etoxi]bencil]tiazolidina-2,4-diona (Compuesto I) se trata conuna fuente adecuada de iones contrarios de hidrocloruro y una cantidad apropiada de agua para la formacion del Hidrato de Hidrocloruro; y después de esto serecupera el compuesto requerido.
ARP000101868A 1999-04-20 2000-04-19 Un procedimiento para el dihidrato del hidrocloruro derivado de la tiazolidina-2,4-diona AR023566A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9909041.7A GB9909041D0 (en) 1999-04-20 1999-04-20 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
AR023566A1 true AR023566A1 (es) 2002-09-04

Family

ID=10851901

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP000101868A AR023566A1 (es) 1999-04-20 2000-04-19 Un procedimiento para el dihidrato del hidrocloruro derivado de la tiazolidina-2,4-diona
ARP000101863A AR023562A1 (es) 1999-04-20 2000-04-19 Derivado de tiazolidin-2,4-diona, una composicion farmaceutica que los comprende, y el uso del mismo para la fabricacion del medicamento

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP000101863A AR023562A1 (es) 1999-04-20 2000-04-19 Derivado de tiazolidin-2,4-diona, una composicion farmaceutica que los comprende, y el uso del mismo para la fabricacion del medicamento

Country Status (42)

Country Link
EP (2) EP1173436B1 (es)
JP (2) JP4283449B2 (es)
KR (1) KR100601244B1 (es)
CN (2) CN1327447A (es)
AP (1) AP1562A (es)
AR (2) AR023566A1 (es)
AT (1) ATE268770T1 (es)
AU (2) AU4130900A (es)
BG (1) BG65864B1 (es)
BR (1) BR0009897A (es)
CA (1) CA2382036A1 (es)
CO (1) CO5170422A1 (es)
CZ (1) CZ300653B6 (es)
DE (1) DE60011419T2 (es)
DK (1) DK1173436T3 (es)
DZ (1) DZ3162A1 (es)
EA (1) EA004232B1 (es)
EG (1) EG24063A (es)
ES (1) ES2218146T3 (es)
GB (1) GB9909041D0 (es)
HK (1) HK1045151B (es)
HR (1) HRP20010770B1 (es)
HU (1) HUP0200865A3 (es)
IL (1) IL146078A0 (es)
MA (1) MA26783A1 (es)
MX (1) MXPA01010696A (es)
MY (1) MY126034A (es)
NO (1) NO320609B1 (es)
NZ (1) NZ515166A (es)
OA (1) OA11866A (es)
PE (1) PE20010050A1 (es)
PL (1) PL351135A1 (es)
PT (1) PT1173436E (es)
RS (1) RS50136B (es)
SI (1) SI1173436T1 (es)
SK (1) SK284991B6 (es)
TR (1) TR200103040T2 (es)
TW (1) TWI277616B (es)
UA (1) UA71615C2 (es)
UY (1) UY26112A1 (es)
WO (1) WO2000063205A2 (es)
ZA (1) ZA200108720B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9909041D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
GB0006133D0 (en) 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical
GB0014005D0 (en) * 2000-06-08 2000-08-02 Smithkline Beecham Plc Novel pharmaceutical
AU2002343050A1 (en) * 2001-11-21 2003-06-10 Smithkline Beecham P.L.C. 5-(4-(2-(n-methyl-n-(2-pyridil) amino) ethoxy) benzyl) thiazolidine-2, 4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thereof; and its use as pharmaceutical active ingredient
GB0129872D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
CZ296468B6 (cs) * 2004-06-10 2006-03-15 Zentiva, A. S. Sul kyseliny fosforecné s 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidin-2,4-dionema zpusob její prípravy
CZ2004844A3 (cs) * 2004-07-27 2006-03-15 Zentiva, A. S Sul kyseliny stavelové s 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidin-2,4-dionu azpusob její prípravy a její pouzití
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
EP1842850A1 (en) * 2006-03-23 2007-10-10 Sandoz AG Rosiglitazone hydrochloride hemihydrate

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE186724T1 (de) * 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9726563D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726566D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726568D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9909041D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
OA11866A (en) 2006-03-02
SK14902001A3 (sk) 2002-02-05
HRP20010770A2 (en) 2002-10-31
EA004232B1 (ru) 2004-02-26
CO5170422A1 (es) 2002-06-27
SI1173436T1 (en) 2004-12-31
BR0009897A (pt) 2002-04-16
TWI277616B (en) 2007-04-01
ATE268770T1 (de) 2004-06-15
UY26112A1 (es) 2000-12-29
PE20010050A1 (es) 2001-03-10
NO320609B1 (no) 2005-12-27
NO20015104D0 (no) 2001-10-19
WO2000063205A3 (en) 2001-01-25
RS50136B (sr) 2009-03-25
CN1327447A (zh) 2001-12-19
BG106112A (bg) 2002-05-31
BG65864B1 (bg) 2010-03-31
KR20010110791A (ko) 2001-12-13
EP1411055A1 (en) 2004-04-21
MA26783A1 (fr) 2004-12-20
CN101134756A (zh) 2008-03-05
DE60011419D1 (de) 2004-07-15
NZ515166A (en) 2004-02-27
EP1173436A2 (en) 2002-01-23
HK1045151B (zh) 2005-03-18
UA71615C2 (uk) 2004-12-15
IL146078A0 (en) 2002-07-25
JP2002542242A (ja) 2002-12-10
PL351135A1 (en) 2003-03-24
JP4283449B2 (ja) 2009-06-24
HUP0200865A2 (en) 2002-08-28
WO2000063205A2 (en) 2000-10-26
PT1173436E (pt) 2004-10-29
GB9909041D0 (en) 1999-06-16
SK284991B6 (sk) 2006-04-06
AU2755202A (en) 2002-05-16
HK1045151A1 (en) 2002-11-15
CA2382036A1 (en) 2000-10-26
KR100601244B1 (ko) 2006-07-19
AU4130900A (en) 2000-11-02
HRP20010770B1 (en) 2005-06-30
YU81501A (sh) 2004-07-15
AR023562A1 (es) 2002-09-04
TR200103040T2 (tr) 2002-04-22
DE60011419T2 (de) 2005-06-16
ZA200108720B (en) 2002-11-28
AP2001002331A0 (en) 2000-04-19
ES2218146T3 (es) 2004-11-16
EA200101101A1 (ru) 2002-04-25
DZ3162A1 (fr) 2000-10-26
JP2009143954A (ja) 2009-07-02
MY126034A (en) 2006-09-29
NO20015104L (no) 2001-12-19
AU765911B2 (en) 2003-10-02
MXPA01010696A (es) 2002-06-04
HUP0200865A3 (en) 2005-04-28
CZ300653B6 (cs) 2009-07-08
EG24063A (en) 2008-05-08
EP1173436B1 (en) 2004-06-09
CZ20013759A3 (cs) 2002-05-15
AP1562A (en) 2006-02-01
DK1173436T3 (da) 2004-09-27

Similar Documents

Publication Publication Date Title
AP1545A (en) Hydrochloride salts of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione.
AR023566A1 (es) Un procedimiento para el dihidrato del hidrocloruro derivado de la tiazolidina-2,4-diona
NZ515163A (en) Thiazolidinedione derivative and its use as antidiabetic
BG104603A (en) 5-[4-[2-(n-methyl-n-(2-pyridyl)amino) ethoxy]benzyl]thiazolidine-2,4-dione, maleic acid salt, hydrate as pharmaceutical
CY1106226T1 (el) Μεσυλικο αλας 5-[4-[2-(ν-μεθυλ-ν-(2-πυριδυλ)αμινο)αιθοξυ]βενζυλ]θειαζολιδινο-2,4-διονης
AP1441A (en) Hydrate of 5- [4-{2-(N-methlyl-N-(2-pyridil) amino) ethoxy} benzyl] thiazolidine-2,4-dione maleic acid salt.
MY129475A (en) Process for the preparation of substituted thiazolidinedione
CO5170420A1 (es) Nuevos farmacos hidrocloruro
AP1600A (en) Combination of a thiazolidinedione and a sulphonylurea for treating diabetes
DK1446404T3 (da) Rosiglitazonedisylater og deres anvendelse som antidiabetika
GB0021784D0 (en) Novel pharmaceutical
AP1785A (en) Tartrate salt of thiazolidinedione derivative.
AP2002002673A0 (en) Thiazolidinedione salt for the treatment of diabetes mellitus.
NZ524933A (en) Sodium salts of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione and pharmaceutical composition thereof
AP2002002684A0 (en) 5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2-pyridyl) amino) ethoxy)benzyl) thiazolidine-2,4-dione hydriodide as pharmaceutical
ECSP003435A (es) Nuevos compuestos
AP1841A (en) A thiazolidinedione derivative and its use as antidiabetic.
AP1813A (en) Tartrate salts of thiazolidinedione derivative.
ECSP982779A (es) Un hidrato de la sal de acido maleico, proceso para la preparacion, composicion farmaceutica y su uso en medicina
PT102339A (pt) Sal hidrocloreto de um derivado de tiazolidinodiona substituido

Legal Events

Date Code Title Description
FB Suspension of granting procedure